These SNPs are demonstrated to hamper the function of lncRNA ANRIL by disrupting its splicing activity which would result in the modification of expression of genes modulated by lncRNA ANRIL including p15 (INK4b) leading to the likelihood of cancer development [17–19]. The gene discussed is CDKN2B-AS1; the disease is cancer.